GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Synlab AG (FRA:SYAB) » Definitions » Inventories, Finished Goods

Synlab AG (FRA:SYAB) Inventories, Finished Goods : €0 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Synlab AG Inventories, Finished Goods?

Synlab AG's quarterly finished goods increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€1 Mil) but then declined from Dec. 2023 (€1 Mil) to Mar. 2024 (€0 Mil).

Synlab AG's annual finished goods increased from Dec. 2021 (€2 Mil) to Dec. 2022 (€2 Mil) but then declined from Dec. 2022 (€2 Mil) to Dec. 2023 (€1 Mil).


Synlab AG Inventories, Finished Goods Historical Data

The historical data trend for Synlab AG's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synlab AG Inventories, Finished Goods Chart

Synlab AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
2.21 1.54 2.10 1.09

Synlab AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.02 - 1.09 -

Synlab AG Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Synlab AG (FRA:SYAB) Business Description

Traded in Other Exchanges
Address
Moosacher Strasse 88, Augsburg, BY, DEU, 80809
Synlab AG is a medical diagnostics services provider in Europe. It offers a range of medical diagnostic services for practising doctors, clinics, and patients. Its geographical segments include France; Germany; South and North and East. The company derives a majority of revenue from the North and East.

Synlab AG (FRA:SYAB) Headlines

No Headlines